C-reactive protein as a novel biomarker

Reactant can flag atherosclerosis and help predict cardiac events

Nader Elgharib Drs Elgharib, Younis, and Wehbe are third-year residents, Dr Chi is professor and chief of the division of biomedical research, and Dr Krishnaswamy is professor and chief of the division of allergy and immunology, department of internal medicine, James H. Quillen College of Medicine, East Tennessee State University, Johnson City.

, MD,

David S. Chi Drs Elgharib, Younis, and Wehbe are third-year residents, Dr Chi is professor and chief of the division of biomedical research, and Dr Krishnaswamy is professor and chief of the division of allergy and immunology, department of internal medicine, James H. Quillen College of Medicine, East Tennessee State University, Johnson City.

, PhD,

Walid Younis Drs Elgharib, Younis, and Wehbe are third-year residents, Dr Chi is professor and chief of the division of biomedical research, and Dr Krishnaswamy is professor and chief of the division of allergy and immunology, department of internal medicine, James H. Quillen College of Medicine, East Tennessee State University, Johnson City.

, MD,

Salim Wehbe Drs Elgharib, Younis, and Wehbe are third-year residents, Dr Chi is professor and chief of the division of biomedical research, and Dr Krishnaswamy is professor and chief of the division of allergy and immunology, department of internal medicine, James H. Quillen College of Medicine, East Tennessee State University, Johnson City.

, MD &

Guha Krishnaswamy Drs Elgharib, Younis, and Wehbe are third-year residents, Dr Chi is professor and chief of the division of biomedical research, and Dr Krishnaswamy is professor and chief of the division of allergy and immunology, department of internal medicine, James H. Quillen College of Medicine, East Tennessee State University, Johnson City.Correspondence[email protected]

, MD

PREVIEW

C-reactive protein (CRP) is a relatively nonspecific marker of inflammation. However, it can be used to monitor the severity and progression of some well-defined cardiovascular diseases. For example, it can predict serious events in patients with coronary artery disease (CAD) who are hospitalized with acute coronary syndrome, myocardial infarction (MI), or advanced peripheral vascular disease. In this article, the authors review the role of CRP in the diagnosis, monitoring, and treatment of various forms of ischemic and inflammatory cardiovascular disease.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

C-reactive protein as a novel biomarker

Reactant can flag atherosclerosis and help predict cardiac events

Information for

Open access

Opportunities

Help and information

C-reactive protein as a novel biomarker

Reactant can flag atherosclerosis and help predict cardiac events

PREVIEW

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature